Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation-Reference-Cited by-同舟云学术

Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation

Published:2015-05 Issue:5 Volume:26 Page:1012-1018
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fu S.,Hou M.M.,Naing A.,Janku F.,Hess K.,Zinner R.,Subbiah V.,Hong D.,Wheler J.,Piha-Paul S.,Tsimberidou A.,Karp D.,Araujo D.,Kee B.,Hwu P.,Wolff R.,Kurzrock R.,Meric-Bernstam F.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/5/1012/19446332/mdv066.pdf

Reference29 articles.

1. Development of hypoxia in a preclinical model of tumor micrometastases;Simonsen;Int J Radiat Oncol Biol Phys,2010

2. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis;Ebos;Cancer Cell,2009

3. Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha;Fath;J Biol Chem,2006

4. Regulation of the HIF-1alpha stability by histone deacetylases;Kim;Oncol Rep,2007

5. Hypoxia-inducible factors, stem cells, and cancer;Keith;Cell,2007

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds;Biochemical Pharmacology;2024-08

2. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions;European Journal of Medicinal Chemistry;2024-06

3. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy;Cancer Communications;2024-02-04

4. Three novel rare TP53 fusion mutations in a patient with multiple primary cancers: a case report;Oncology and Translational Medicine;2024-01-07

5. Restoration of Tumor Suppression to Cancer Carrying p53 Mutations;Molecular Diagnostics of Cancer [Working Title];2023-12-22